Retatrutide, mai yuwuwar magani ga cutar Alzheimer, ya sami ci gaba a cikin sabuwar gwaji na asibiti, yana nuna sakamako mai ban sha'awa. Wannan labari ya ba da bege ga miliyoyin marasa lafiya da iyalansu da wannan mummunar cuta ta shafa a duniya. Retarglutide wani sabon magani ne wanda wani babban kamfanin harhada magunguna ke kera shi musamman wanda aka kera don kai hari kan tushen cutar cutar Alzheimer. An ƙera ta ne don tarwatsa samuwar da kuma tara tarin beta-amyloid plaques a cikin kwakwalwa, ɗaya daga cikin alamomin cutar. An gudanar da gwaje-gwajen asibiti a cikin shekaru biyu da suka gabata kuma sun haɗa da adadi mai yawa na masu cutar Alzheimer na kungiyoyi daban-daban da kuma matakan cutar. Sakamako ya nuna cewa retarglutide yana rage raguwar fahimi da haɓaka aikin ƙwaƙwalwar ajiya a cikin marasa lafiya yayin gwaji. Dokta Sarah Johnson, shugabar masu binciken, ta bayyana kyakkyawan fata game da binciken. Ta ce: "Sakamakon gwajin mu na asibiti ya nuna cewa retarglutide yana da yuwuwar zama mai canza wasa a cikin binciken Alzheimer. Ba wai kawai ya nuna tasiri mai mahimmanci wajen rage ci gaban cutar ba; tsaro." Retarglutide yana aiki ta hanyar ɗaure zuwa amyloid beta, yana hana haɗuwa da samuwar plaque na gaba.
Ana sa ran wannan tsarin aikin zai yi tasiri mai zurfi kan dakatar da illar cutar Alzheimer da kuma kare aikin fahimi na marasa lafiya. Duk da yake waɗannan sakamakon gwaji na farko suna da ban ƙarfafa, ana buƙatar ƙarin gwaji don tantance tasiri na dogon lokaci, aminci, da yuwuwar illolin retalglutide. Kamfanin harhada magunguna yana shirin ƙaddamar da manyan gwaje-gwajen da suka shafi yawan majinyata daban-daban a cikin watanni masu zuwa. Cutar Alzheimer cuta ce ta neurodegenerative wacce ke shafar kusan mutane miliyan 50 a duk duniya. Yana da alaƙa da raguwar ci gaba a ƙwaƙwalwar ajiya, tunani, da ɗabi'a, a ƙarshe yana haifar da cikakken dogaro ga wasu don ayyukan yau da kullun. A halin yanzu, zaɓuɓɓukan magani da ake da su suna iyakance, yana sa gano ingantattun magungunan warkewa ya fi mahimmanci. Idan retarglutide ya yi nasara a matakin ƙarshe na gwaji na asibiti, yana da yuwuwar yin juyin juya hali da kulawa da cutar Alzheimer. Marasa lafiya da danginsu na iya a ƙarshe ganin alamar bege yayin da suke yaƙi da wannan muguwar cuta. Yayin da hanyar retarglutide zuwa amincewar tsari da kuma amfani da yaɗuwar na iya daɗe, waɗannan sabbin sakamakon gwaji na asibiti suna ƙarfafa fata da sabunta ƙuduri a cikin al'ummomin kimiyya da na likitanci. Ci gaba da bincike game da wannan magani yana ba da haske ga kyakkyawar makoma ga miliyoyin mutanen da ke fama da cutar Alzheimer. Disclaimer: Wannan labarin ya dogara ne akan sakamakon gwaji na asibiti na farko kuma bai kamata a yi la'akari da shawarar likita ba. Ana ba da shawarar tuntuɓar ƙwararrun kiwon lafiya don keɓaɓɓen jagora game da cutar Alzheimer da zaɓuɓɓukan magani.
Lokacin aikawa: Nov-01-2023